Use of myocardial perfusion imaging to predict the effectiveness of coronary revascularisation in patients with stable angina pectoris

被引:12
作者
Johansen, A
Hoilund-Carlsen, PF
Christensen, HW
Vach, W
Moldrup, M
Haghfelt, T
机构
[1] Odense Univ Hosp, Dept Nucl Med, DK-5000 Odense, Denmark
[2] Odense Univ Hosp, Dept Clin Physiol & Nucl Med, DK-5000 Odense, Denmark
[3] Odense Univ Hosp, Nordic Inst Chiropract & Clin Biomechan, DK-5000 Odense, Denmark
[4] Univ So Denmark, Dept Stat, Odense, Denmark
[5] Odense Univ Hosp, Dept Cardiol, DK-5000 Odense, Denmark
关键词
angina pectoris; radionuclide imaging; SPECT; myocardial revascularisation; myocardial ischaemia; ARTERY-BYPASS-SURGERY; EMISSION COMPUTED-TOMOGRAPHY; FOLLOW-UP; RANDOMIZED-TRIAL; MEDICAL THERAPY; HEART-DISEASE; GRAFT-SURGERY; ANGIOPLASTY; METAANALYSIS; VIABILITY;
D O I
10.1007/s00259-005-1799-7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: Coronary revascularisation is the treatment of choice in patients with stable angina who have significant stenoses. From a pathophysiological point of view, however, mitigation of angina is to be expected only in the presence of reversible ischaemia. Therefore it was the aim of this study to examine the effect of revascularisation on stable angina in relation to the myocardial perfusion imaging (MPI) pattern prior to intervention. Methods: Three hundred and eighty-four patients (58.0 +/- 8.8 years) referred for angiography underwent MPI. Prior to MPI and at 2-year follow-up, patients were classified as having typical angina, atypical angina, non-cardiac chest pain or no pain, and the severity of chest pain was graded according to the Canadian Cardiovascular Society (CCS) criteria. The patients themselves estimated their pain on a visual analogue scale. Management was based on symptoms and angiographic findings, since the results of MPI were not communicated. Results: Among the 240 patients who were not revascularised, 79% had typical or atypical angina at study entrance versus 40% at follow-up. In comparison, 93% of the 144 revascularised patients had typical or atypical angina before intervention versus only 36% at follow-up. This additional advantage of invasive therapy was present only in patients with reversible defects; revascularisation had no additional effect in patients with normal perfusion or irreversible defects. Similarly, additional, significant reductions in CCS class and visual analogue score were observed exclusively in patients with reversible defects. Conclusion: In patients referred for coronary angiography owing to known or suspected stable angina, revascularisation was significantly more effective than medical treatment exclusively in patients with reversible ischaemia.
引用
收藏
页码:1363 / 1370
页数:8
相关论文
共 35 条
[1]  
Alderman EL, 1997, JAMA-J AM MED ASSOC, V277, P715
[2]   10-YEAR FOLLOW-UP OF SURVIVAL AND MYOCARDIAL-INFARCTION IN THE RANDOMIZED CORONARY-ARTERY SURGERY STUDY [J].
ALDERMAN, EL ;
BOURASSA, MG ;
COHEN, LS ;
DAVIS, KB ;
KAISER, GG ;
KILLIP, T ;
MOCK, MB ;
PETTINGER, M ;
ROBERTSON, TL .
CIRCULATION, 1990, 82 (05) :1629-1646
[3]  
Alderman EL, 2000, J AM COLL CARDIOL, V35, P1122
[4]   Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis [J].
Allman, KC ;
Shaw, LJ ;
Hachamovitch, R ;
Udelson, JE .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (07) :1151-1158
[5]   The role of nuclear cardiology in clinical decision making [J].
Berman, DS ;
Germano, G ;
Shaw, LJ .
SEMINARS IN NUCLEAR MEDICINE, 1999, 29 (04) :280-297
[6]   SEPARATE ACQUISITION REST THALLIUM-201/STRESS TC-99M SESTAMIBI DUAL-ISOTOPE MYOCARDIAL PERFUSION SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY - A CLINICAL VALIDATION-STUDY [J].
BERMAN, DS ;
KIAT, H ;
FRIEDMAN, JD ;
WANG, FP ;
VANTRAIN, K ;
MATZER, L ;
MADDAHI, J ;
GERMANO, G .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (05) :1455-1464
[7]   Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials [J].
Bucher, HC ;
Hengstler, P ;
Schindler, C ;
Guyatt, GH .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7253) :73-77
[8]  
CAMPEAU L, 1976, CIRCULATION, V54, P5223
[9]  
CHRISTENSEN HW, 2003, J NUCL CARDIOL, V10, pS65
[10]  
DETRE KM, 1984, NEW ENGL J MED, V311, P1333